Skip to main content
main-content

Diabetes complications and comorbidities: Ketoacidosis

medwireNews top story

Data highlight opportunities to diagnose type 1 diabetes before DKA onset

Child with diabetes (symbolic image with model)

Children with type 1 diabetes are more likely than their non-diabetic peers to seek primary care for a number of specific conditions in the year before their diagnosis, which could aid detection before the onset of diabetic ketoacidosis, say researchers.

medwireNews top story

Recommendations issued for managing SGLT2 inhibitor-associated DKA risk in type 1 diabetes

Checkboxes

Experts have developed consensus recommendations for minimizing diabetic ketoacidosis risk in patients with type 1 diabetes treated with SGLT2 inhibitors.

Interactive patient case study

Renal complications in diabetic ketoacidosis

Renal complications in diabetic ketoacidosis

This 15-minute case presents likely causes of renal complications in diabetic ketoacidosis and explains how to identify the signs and symptoms of renal complications to ensure early initiation of appropriate treatment.

Get more on: Diabetic ketoacidosis | Pediatric diabetes | Nephropathy

medwireNews editor's pick

EASE: Add-on empagliflozin improves glycemic control in type 1 diabetes

Pills

The addition of empagliflozin to insulin therapy reduces glycated hemoglobin levels in patients with type 1 diabetes, indicate findings from the phase III EASE-2 and 3 trials.

Case study

Acute illness while on a SGLT2 inhibitor and ketogenic diet

AdobeStock_88855376

Advisory Board member Theresa Smyth tackles an emergency case involving a type 2 diabetes patient on a new diet and treated with empagliflozin. What went wrong and how should he be managed? [Read more].

Get more on: SGLT2 inhibitors | Diet and nutritional management

medwireNews editor's pick

Fluid management strategy absolved of neurologic injury blame in childhood DKA

Child on iv drip

Neither the rate of administration nor the sodium chloride content of replacement fluids given to children with diabetic ketoacidosis influences their neurologic outcomes, show the results of the PECARN DKA FLUID Study.

Case report

Sudden onset of immune-mediated type 1 diabetes mellitus in a 93-year-old woman: A case report

Elderly patient with doctor

Oriot and colleagues report a case of sudden onset autoimmune type 1 diabetes with ketoacidosis in a 93-year-old woman, and summarize the available literature [read more].
Oriot P et al. Acta Diabetol 2018. doi: 10.1007/s00592-018-1170-7

Get more on: Flash glucose monitoring | Older adults | Ketoacidosis | Type 1 diabetes medication

Patient case study

Atypical diabetes: Case study 4

Diagnosis

Can you diagnose the atypical form of diabetes presented in our fourth patient case study? Test your knowledge with Editorial Board member, Jay Shubrook [read more].

Get more on: Other types of diabetes | Ketoacidosis

Case report

Prediabetes directly deteriorates into diabetic ketoacidosis and hyperosmolar hyperglycemic syndrome triggered by acute pancreatitis: A case report illustrating a “chicken and egg” paradigm in ketosis-prone diabetes

Woman with abdominal pain (symbolic image with model)

The authors report the case of a 45-year-old woman with a past medical history of prediabetes who presents with postprandial left upper quadrant abdominal pain, nausea, and vomiting [read more].
Song R, Cao S. Diabetes Ther 2018; 9: 1377. doi: 10.1007/s13300-018-0417-1

Get more on:  Diabetic complications | Prediabetes and prevention

Expert opinion editorial

Sodium-glucose cotransporter 2 inhibitors for type 1 diabetes: Ready for prime time?

Traffic light

Editorial board member John Wilding casts a critical eye over the positive buzz surrounding the potential uses of sodium-glucose cotransporter 2 inhibitors in type 1 diabetes treatment [read more].

Get more on: Medications | Type 1 diabetes | SGLT2 inhibitors

medwireNews

04-12-2019 | Sotagliflozin | News

Meta-analysis demonstrates benefits of add-on sotagliflozin in type 1 diabetes

Adding the SGLT1/2 inhibitor sotagliflozin to insulin treatment improves glycemic and non-glycemic outcomes among people with type 1 diabetes, but at the cost of an increased risk for diabetic ketoacidosis, researchers report in The BMJ.

02-19-2019 | Ketoacidosis | Highlight | News

Data highlight opportunities to diagnose type 1 diabetes before DKA onset

Children with type 1 diabetes are more likely than their non-diabetic peers to seek primary care for a number of specific conditions in the year before their diagnosis, which could aid detection before the onset of diabetic ketoacidosis, say researchers.

02-12-2019 | SGLT2 inhibitors | Highlight | News

Recommendations issued for managing SGLT inhibitor-associated DKA risk in type 1 diabetes

Experts have developed consensus recommendations for minimizing diabetic ketoacidosis risk in patients with type 1 diabetes treated with SGLT inhibitors.

Interactive patient case study

12-21-2018 | Ketoacidosis | Case study | Link

Renal complications in diabetic ketoacidosis

Develop and test your knowledge on the renal complications associated with diabetic ketoacidosis through this practical example and self-assessment authored by Professor Francesco Chiarelli. This 15-minute case presents likely causes of renal complications in diabetic ketoacidosis and explains how to identify the signs and symptoms of renal complications to ensure early initiation of appropriate treatment.

Themed collections

06-25-2018 | SGLT2 inhibitors | Themed collection | Collection

Sodium-glucose cotransporter-2 inhibitors in type 2 diabetes

An updated collection of articles focusing on the mechanism of action and clinical use of sodium-glucose cotransporter-2 inhibitors in patients with diabetes.

Journal articles and book chapters

08-15-2018 | Pregnancy | Review | Article

Inpatient glycemic management of the pregnant patient

Yeh T, Yeung M, Mendelsohn Curanaj FA. Curr Diab Rep 2018; 18: 73. doi: 10.1007/s11892-018-1045-x

07-23-2018 | SGLT2 inhibitors | Review | Article

SGLT2 inhibitors in type 2 diabetes management: Key evidence and implications for clinical practice

Wilding J et al. Diabetes Ther 2018. doi: 10.1007/s13300-018-0471-8

06-26-2018 | Devices and technology | Review | Article

Technology in the management of type 1 diabetes mellitus: Current status and future prospects

Tauschmann M Hovorka R. Nat Rev Rheumatol 2018. doi: 10.1038/s41574-018-0044-y

06-24-2018 | Drug-induced diabetes | Article

Collateral damage: Insulin-dependent diabetes induced with checkpoint inhibitors

Stamatouli AM et al. Diabetes 2018. doi: 10.2337/dbi18-0002

Guidelines

A convenient single access point, providing diabetes professionals with links to a comprehensive set of clinical practice guidelines from a wide range of relevant organizations.

Slides

Downloadable PowerPoint slide sets containing a variety of high-quality images and illustrations from Springer Nature’s library of published figures.

Practice tips

Practical information, guidance, and helpful resources for diabetes healthcare providers. Comprised of practical approaches, case studies, and more.

Themed collections

Compendia of selected, recently published, free full-text journal and book content from Springer Nature and other publishers on a particular topic within diabetes management, as recommended by our Editorial Board.

Independent Medical Education

Educational programs building upon the most current research and professional practice recommendations, with the aim of enabling more efficient diagnosis, optimizing treatment, and improving patient outcomes.

image credits